Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT06356363
  4. Details
NCT06356363 Clinical Trial

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

Cancer Clinical Trial

— OncoPREMs  

Official title:
Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06356363
Other study ID # 2023_RIPH_005_OncoPREMs
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2024
Est. completion date November 1, 2025

Study information
Verified date April 2024
Source Institut Jean-Godinot
Contact Barbe Coralie, DR
Phone 0326918822
Email coralie.barbe1@univ-reims.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Healthcare systems are evolving, giving increasing prominence to the patient-centered model, accompanied by objective and perceived outcomes. PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their experience of care. PREMs enable patients to take an active role in their own care, and enable healthcare establishments to identify areas for improvement that can be incorporated into their quality processes. In oncology, the collection of patient-perceived quality regarding their care pathway would enable better coordination of their care. While a few initiatives have emerged in the field of PREMs, the development of a reliable questionnaire assessing patient perception of their care pathway in oncology remains a challenge.

Description:

The aims of the study are to constitute a questionnaire to assess patients' perceptions of their oncology care pathway and to perform its psychometric validation.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 500
Est. completion date November 1, 2025
Est. primary completion date November 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - cancer patient - regardless of location or stage - Fluent in French - aged more than 18 years old - Agreeing to take part in the study Exclusion Criteria: - With an estimated life expectancy of less than 3 months - In remission, untreated or without follow-up for more than 12 months - Protected by law

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Data collection
data collection

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Institut Jean-Godinot Université de Reims Champagne-Ardenne

Outcome
Type Measure Description Time frame Safety issue
Primary Psychometric validation Stastistical analysis to confirm the psychometric validation of the IGQ questionnaire Day 0
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients